Category: Education

Autoimmune rheumatic diseases are complex. Living with an autoimmune rheumatic disease involves more than physical symptoms, impacting one’s quality of life, mental health, and daily activities. 

 

The most well known form of rheumatism is rheumatoid arthritis (RA), an autoimmune and inflammatory disease where one’s immune system attacks healthy cells in the body, causing painful inflammation. RA effects mainly the joints and typically many joints at once. The lining of the joint becomes inflamed, causing damage to the tissue and long-term chronic pain, loss of balance, and deformity. RA can also affect other tissues throughout the body and cause problems in organs such as the lungs, heart and eyes. 

 

Childhood arthritis is also known as Juvenile idiopathic arthritis (JIA). While children often outgrow it, the early onset of damage can make it hard for a child to do everyday activities such as walking or dressing and may result in a disability. Even with potentially achieving permanent remission, any physical damage to the joint may remain. 

 

As of today, there is no cure for this autoimmune disease and symptoms are addressed on an individual basis. Recommendations for combination therapies include:

 

• Increasing physical activity/muscle strengthening exercises
• Weight loss
• OTC pain relievers
• Crutches/canes
• Surgery, if all other resources are exhausted
• And, more recently researched, cannabinoid therapy 

 

The Endocannabinoid System (ECS) and RA

 

To understand the role of the ECS in RA, Richardson et al. examined the synovial fluid of 32 osteoarthritis patients and 13 rheumatoid arthritis patients following knee arthroplasty. The endocannabinoid 2-Arachidonoylglycerol (2-AG) and cannabinoid receptors 1 and 2 (CB1 and CB2) were present in the synovia of patients with end-stage osteoarthritis and rheumatoid arthritis, but not in healthy donors. These findings suggest that the ECS is involved in the development of rheumatic diseases. 

 

Cannabinoids and Pain

 

A characteristic of rheumatism is chronic pain, where adequate treatments fall short. Therefore, there is a strong need for alternative therapies. Medicinal cannabis extracts on chronic pain have been evaluated across several trials. Statistically significant improvements have been observed with delta-9-tetrahydrocannabinol (THC) extracts as well as a combination of cannabinoid (CBD) to THC on RA patients, with only mild side effects. In addition to pain, patients reported improvements for sleep quality. 

 

A review of clinical trials of pain reduction by cannabis show that cannabis-based medications were most effective as adjunct therapy in multiple sclerosis and in managing chronic rheumatoid pain.

 

A 2021 analysis of 29,000 patients, where 10,873 were cannabis users concluded that about 20% of patients with rheumatoid diseases who actively consume cannabis self-reported an improvement in pain. 

 

Cannabinoids for Immunomodulatory Effects

 

Cannabinoids mediate their therapeutic effects through CB1 and CB2 receptors located throughout our brain and body.

 

The fact that both CB1 and CB2 receptors are expressed by immune cells suggests that cannabinoids play important roles in the regulation of the immune system. Cannabinoids are commonly investigated as pain-relieving agents, but in recent years more evidence has accumulated on their potential immunomodulatory effect, supported by results in animal models of certain rheumatic diseases. 

 

Many studies point to CBD for its ability to reduce the formation of reactive oxygen species and nitric oxide in animal models of inflammation. One study noted CBD to have a “potent capacity to effectively suppress cytokine storms in a mouse model” (Aswad et al., 2022). Further evidence on cannabinoids and the immune system looks to THC and its ability to aid in preventing the activation of inflammatory signaling pathways. 

 

Cannabinoids as anti-inflammatories

 

CBD has a wide spectrum of biological activity, including anti-inflammatory activity. This is why its activity in the prevention and treatment of diseases whose development is associated with inflammation has been tested. Clinical studies have confirmed that CBD reduces the levels of proinflammatory cytokines, inhibits T-cell proliferation, induces T-cell apoptosis and reduces migration and adhesion of immune cells. 

 

In addition, CBD creates a physiological response with several inflammatory mediator receptors within us. These are known as the PPARy, GPR, and Adenosine A2A Receptors. 

 

The anti-inflammatory contributions of THC are also notable. In 1991, Evans demonstrated that THC has twenty times the anti-inflammatory potency of aspirin and twice that of hydrocortisone. 

 

Takeaway

 

Cannabinoids show promising results for anti-arthritic properties, notably due to their analgesic, immunomodulatory, and anti-inflammatory actions. However clinical studies for RA specifically and studies focusing on commercially available products are limited. The cannabis plant contains hundreds of compounds, including various cannabinoids, terpenes, and flavonoids. Specific strains may benefit some conditions more than others and only further research will build this understanding so patients may have more accurate, targeted therapy. 

 

To join research, receive updates on cannabis education, or to chat with our care team to discuss anything cannabinoid therapy related one on one, contact Realm of Caring today.

 

Additionally, following Realm of Caring on social media (Instagram or Facebook) during Autoimmune Awareness Month can provide valuable insights and foster a supportive community for those affected. 

 

if you want to reach out to our care team to discuss anything cannabinoid therapy related one on one – we are here for you! You can email or call our care team directly or head to our contact us section to schedule an appointment. 

 

According to the Multiple Sclerosis (MS) Journal, nearly 1 million Americans are affected by MS,  a number that continues to grow daily, with the majority of those affected being women. MS is an autoimmune disease which affects your body’s nervous system, specifically damaging the insulation that surrounds nerve fibers. The three most common types of MS are:

 

• Relapsing-remitting MS (RRMS)
• Secondary-progressive MS (SPMS)
• Primary-Progressive MS (PPMS)

 

Once diagnosed, slowing the progression of the disease may require several lifestyle changes such as nutrition, exercise, mental well-being, and therapies. Multidisciplinary approaches are often suggested to help diagnosed individuals live a full life. 

 

Cannabis has been looked to for its healing properties for millennia. To date, a plethora of diseases such as anorexia, emesis, pain, inflammation, neurodegenerative disorders, epilepsy, glaucoma, osteoporosis, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome, and MS are either being treated with or have the potential to be treated by cannabinoid antagonists, agonists, and related compounds. 

 

The efficacy of Cannabis sativa has been assessed for the management of MS at a cellular level but also for symptoms, including spasticity, pain, tremors, ataxia, bladder functions, sleep, and quality of life. Cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), derived from the Cannabis sativa plant, have shown through research to have anti-inflammatory and antioxidant benefits.

 

Immune Cell Modulation

 

Toll-like receptors (TLRs) have been demonstrated through human and animal studies to be key players in MS pathogenesis. Data indicate that THC and CBD can act as TLRs modulating drugs in primary immune cells, offering insight to the cellular targets the phytocannabinoids may have in eliminating inflammation for MS. In one 2022 published study, the anti-inflammatory potential of THC and CBD were compared when delivered alone versus a 1:1 combination. The results highlight that the combination of the phytocannabinoids was more effective in modulating TLR signaling

 

Spasticity

 

A main psychoactive compound of the Cannabis sativa plant, THC, was discovered in the 1960s and was shown to have activity on the cannabinoid receptor 1 (CB1) in the brain. This has a big impact on the development of cannabinoid therapeutic drugs and their potential to alleviate MS-related spasticity. 

 

Nabiximols (Sativex) is a cannabinoid based medication available in the United Kingdom. It comes in the form of a mouth spray in a 1:1 ratio of THC:CBD. It has been approved for treatment of symptoms of spasticity in adults with MS. A randomized controlled trial published in 2023 reported that nabiximols led to improvement in spasticity that was sustained over the 12-week treatment period. Another study in 2022 evaluated real-world data from the Italian Medicines Agency e-Registry on 1,138 patients with MS. Results showed favorable impacts of nabiximols, resolving a range of MS spasticity-associated symptoms at week 4 and after 18 months for those who continued treatment. 

 

Pain

 

Pain associated with MS includes central neuropathic pain, musculoskeletal pain, and non-neuropathic pain. Cannabis use for pain can be traced back thousands of years. Observationally in research, the response to pain in individuals has been favorable when compared to baselines or controls. 

 

A review of literature published through June 2017 examined trials regarding cannabinoid use for pain in patients with neuropathy and malignant diseases. Out of 18 trials, 15 demonstrated a significant analgesic effect of cannabinoids as compared to placebo, the reduction in pain intensity was considered clinically significant. The most commonly reported adverse effects were well tolerated. 

 

Tremors and Ataxia

 

MS may cause tremors and ataxia in more than 80% of patients due to how it affects the cerebellum. Despite how common these symptoms may be, the pharmacotherapies are often ineffective, therefore there is a need for new treatments with limited side effects. Although one study in 1982 showed the ability of THC to suppress tremors in two of eight MS patients, another showed acute improvements in 1989 and benefits have been seen in mouse models, current human trials to understand cannabis as an effective therapy for tremors and ataxia are insufficient and still needed. 

 

Bladder Function

 

A prevalent symptom in MS patients is lower urinary tract dysfunction, typically appearing in the later stages of the disease. The primary issues are urinary urgency and urge incontinence. 

 

The diverse effects of CB1 and CB2 receptor systems in the lower urinary tract may be novel targets for cannabinoid therapy. Anecdotal reports suggest cannabis may alleviate lower urinary tract symptoms. An open trial published in 2004 evaluated whole-plant Cannabis sativa extracts for patients with advanced MS and refractory lower urinary tract symptoms. Patients began with a 1:1, THC:CBD ratio for eight weeks and then transitioned to THC only for an additional eight weeks. The 15 who were evaluated showed a significant decrease in incontinence with significant improvements in self-reported pain, spasticity, and quality of sleep. Given the few adverse effects, this study suggested cannabis-based medicinal extracts to be a safe and effective treatment. 

 

Sleep

 

Cannabis Sativa is often used for improved sleep and relaxation, attributed to Indian hemp in the nineteenth century. 

 

Hemp seeds contain a vitamin B6 content that can trigger the conversion of our body’s tryptophan into serotonin, which can then be converted to melatonin. 

 

CBD has been researched for its therapeutic potential for sleep disorders through limiting symptoms that may keep us awake at night but also may contribute to an increase in sleep duration and depth, as well as decrease in the anxiety responses induced by sleep disturbance. 

 

In comparison to CBD, THC has shown in studies as having an effect on mental and physical sedation, even in low amounts. THC also has positive therapeutic benefits that may lead to better sleep.

 

Cannabinoids CBD, THC, and CBN have been lightly studied for their effects in balancing melatonin production. Cannabinoids are also being studied to better understand the complementary relationship they have with melatonin. Data published in 2022 suggest that a CBD-melatonin formula could be competitive with synthetic-hypnotic drugs (i.e. Ambien, Unisom). The antioxidant activity of melatonin that benefits the brain network coupled with the pain reduction and anti-anxiety effects of CBD promoted a balanced sensation of wellbeing during sleep. 

 

Quality of Life

 

MS patients have been found to have a lower health-related quality of life than the general population.

 

A qualitative analysis published in 2022 paid close attention to the notable quality of life improvements attributed to medicinal cannabis use. The two overarching categories were “enhanced well-being” and “improved daily functioning”. Enhanced well-being includes feelings such as regaining a sense of hope, enjoying family life, and laughing more often.

 

A review of published studies from 2007 to 2021 on cannabinoid therapy for MS concluded with a moderate certainty of evidence that 1:1 CBD:THC oromucosal spray mixtures as an add-on therapy improved measures of spasticity, pain, and bladder and sleep related quality of life in responders within weeks of starting treatment. 

 

Conclusion

 

Cannabis sativa extracts show promise in alleviating associated symptoms of MS for individuals, so much so that countries have approved botanical or synthetic forms as treatment options. Further studies are warranted to investigate long-term outcomes, dosing, and understanding the mechanisms responsible for inhibiting neuroinflammation and enhancing neuroprotection. 

 

If you or a loved one have questions on how cannabinoid therapy such as how to find a quality product or how to talk with your doctor, the Realm of Caring Care Team is here to help. Reach out, we are here to help. 

 

Following Realm of Caring on social media (Instagram or Facebook) during Autoimmune Awareness Month can provide valuable insights and foster a supportive community for those affected.

Autoimmune diseases present a significant challenge to public health, affecting millions worldwide. In the United States alone, it’s estimated that autoimmune diseases impact approximately 10 million people, accounting for about 3% of the population​​. Globally, the issue is even more pronounced, with a rising trend in autoimmunity, especially among specific demographics, including adults 50 years and older and adolescents. This rise is concerning and suggests an urgent need for awareness and understanding​​.

 

The Impact of Autoimmune Diseases Globally and in the U.S.

 

Autoimmune diseases occur when the body’s immune system mistakenly attacks its own cells, leading to a variety of illnesses. The prevalence of these diseases is increasing, indicating a growing public health concern. The rise in autoimmunity, particularly in the United States, signals a potential increase in future autoimmune diseases, underscoring the importance of Autoimmune Awareness Month as a critical time for education and advocacy​​.

 

Spotlight on Skin-Related Autoimmune Diseases

 

Several autoimmune diseases specifically affect the skin, each with unique symptoms and challenges:

 

• Psoriasis causes rapid skin cell multiplication, resulting in scales and red patches that can be painful and itchy.
• Lupus can lead to a distinctive rash on the face, known as a butterfly rash, among other systemic symptoms.
• Dermatomyositis involves muscle weakness and a distinct skin rash, affecting both the skin and muscle tissues.
• Vitiligo leads to the loss of skin pigment in patches, affecting the skin’s appearance.
• Scleroderma results in skin hardening and tightening, impacting mobility and skin texture.

 

Cannabis and Autoimmune Diseases: Managing Symptoms

 

Cannabis has emerged as a potential ally in managing symptoms of autoimmune diseases, including those affecting the skin. Its properties can help alleviate inflammation, pain, and discomfort associated with various autoimmune conditions.

A 2019 published study tested the effectiveness of CBD-enriched ointment in inflammatory skin conditions that result in scars. Among those in the study, individuals reported suffering from dermatitis, psoriasis, and acne. After a period of three months, the evaluated skin parameters were significantly improved in all 20 volunteers and none reported any worsening. Specifically, the hydration markers increased by nearly 7%. This study concluded by saying that “topical administration of CBD ointment is a safe and effective non invasive alternative for improving the quality of life in patients with some skin disorders, especially on inflammatory background” (Palmieri, et al.).

 

Additionally, cannabigerol (CBG) has powerful anti-inflammatory and antibacterial properties that may add benefit to our skin health. Cannabis products offer a promising avenue for symptom management, but with the caveat of professional guidance. If you’re looking for support on how cannabis could help your autoimmune disease, get connected to one of our Care Team specialists.

Following Realm of Caring on social media (Instagram or Facebook) during Autoimmune Awareness Month can provide valuable insights and foster a supportive community for those affected.

 

Research shows that more than 40% of cancer diagnoses and nearly half of cancer-related deaths can be attributed to preventable causes. The American Association for Cancer Prevention states that it remains imperative that we identify strategies to enhance the dissemination and implementation of our current knowledge of cancer prevention. Preventable causes may include smoking cigarettes, excess body weight, physical inactivity, and sun exposure. While research is not pointing to cannabinoids having a direct role in cancer prevention, several studies demonstrate the ability of cannabinoids, terpenes and flavonoids to promote general well-being and to have anti-cancer activity.

 

Cannabinoids for well-being: smoking cessation

 

New research shows that compounds found naturally in cannabis plants reverse attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. The study, published in the National Library of Medicine, shows that treatment with cannabidiol (CBD), a non-psychoactive cannabinoid found naturally in cannabis, may be a promising novel smoking cessation treatment due to its anxiolytic properties, minimal side effects and research showing that it may modify drug cue salience.

 

Further promising results from preclinical studies suggest that manipulation of the endocannabinoid system (ECS) could be a potential therapeutic strategy for treating nicotine addiction. The possible involvement of the endocannabinoid system in the rewarding effects of nicotine was evaluated by using the conditioned place preference (CPP) in mice.

 

Cannabinoids for well-being: maintaining a healthy weight

 

It is well established that the ECS is involved in the regulation of energy balance and the development of obesity. Cannabinoid receptors regulate thermogenesis, food intake, and inflammation. Cannabinoid receptors are also responsible for the browning of white adipose tissue (the process of burning fat in the body). CBD plays a modulatory role in this process as well as promotes lipid metabolism, therefore is considered a promising therapeutic agent for preventing obesity. 

 

Because the ECS plays a role with our appetite control, from the suppression of appetite to counter over-consumption to the treatment of conditions that involve reduced appetite and weight loss; cannabinoid therapy may be a part of the equation for its potential to support an overall healthy weight.

 

Cannabinoids for well-being: physical activity

 

The many reasons for one to choose not to be physically active involves pain, injury, and lack of energy. Cannabinoid therapy has gained a lot of attention in the athletic community recently for good reason. CBD as well as delta-9-tetrahydrocannabinol (THC) have been researched for their novel anti-inflammatory actions, which enhance recovery time by decreasing muscle tension, soreness, and pain. CBD and THC have also shown beneficial effects for improving bone fracture healing while CBD and cannabigerol (CBG) have shown to ameliorate post-fracture pain as effectively as nonsteroidal anti-inflammatory drugs (NSAIDs), which are known to potentially inhibit bone repair. Cannabinoids such as CBD, THC, and cannabinol (CBN) as well as terpene blends may also promote enhanced sleep, which can have beneficial effects on one’s ability to maintain daily physical activity. 

 

Cannabinoids for well-being: skin benefits

 

Most cases of skin cancer are caused by overexposure to ultraviolet (UV) rays, which can damage skin cells. Among other skin enhancing benefits, CBD has shown that through its antioxidant and anti-inflammatory properties and regulation of protein biosynthesis and degradation, that it may protect skin cells against UVA and UVB induced changes. 

 

Of the cannabinoids researched to date for skin health, CBD is a widespread ingredient in skin care products formulated as body oils, moisturizers, salves, lotions, and balms. THC, and potentially CBN, may also be responsible for skin benefits such as reducing cytokine production and oxidative stress. Additionally, CBG has powerful anti-inflammatory and antibacterial properties that may add benefit to our skin health. 

 

Anti-Cancer Activity of Cannabinoids

 

The Endocannabinoid System (ECS) has been a target for the treatment of various diseases, including neurodegenerative diseases, neuropathic and inflammatory pain, multiple sclerosis, cardiovascular diseases, metabolic syndrome, and more. Cannabinoids have been considered for a long time for alleviating cancer therapy related symptoms, such as controlling nausea and pain, stimulating appetite, and elevating mood. However research findings go beyond symptom relief to include anti-cancer effects. 

 

Cancer cells proliferate rapidly in an uncontrolled manner, therefore one of the most critical components of an anti-cancer therapy is to inhibit the proliferation of cancer cells. Cancer cells have the ability to escape cell death, whereas a normal cell undergoes apoptosis (programmed cell death). Cannabinoids have proved to prevent cancer cells from growing and spreading to surrounding tissue (anti-proliferative) as well as apoptotic. 

 

One of the first studies completed to describe the antineoplastic (or acting to prevent, inhibit, or halt the development of a tumor) activity of cannabinoids was published in 1975. Here it was demonstrated that the administration of Delta-9-THC, Delta-8-THC, and or CBN inhibited the growth of Lewis lung adenocarcinoma cell growth in vitro (outside a living organism) and in vivo (within a living organism) after oral administration to mice. Since this study, there have been several using animal models to show cannabinoids for their efficacy in inhibiting the progression of many types of cancer including glioblastoma, lunch, prostate, colon, and breast cancer.

 

Most existing cancer therapies are not developed to specifically target metastatic progression, despite tumor metastasis accounting for 90% of cancer-related deaths. Breast cancer, in particular, has been noted as typically incurable once clinically apparent metastases develop, therefore there is a need for non-toxic therapeutic interventions to target this progression. There has been compelling evidence of the anti-tumoral activity of cannabinoids in preclinical models of breast cancer, both witnessed in cell culture systems and clinically relevant animal models. It has been proposed in research that targeting both cannabinoid anti-tumor pathways simultaneously, by combining THC and CBD, may lead to enhanced anti-tumor activity.

 

Terpenes

 

Terpenes are compounds found in all known life forms, including fruits, trees, herbs, and a range of other plant species that are responsible for determining their distinct scents. There is a complex diversity and varying concentration of terpenes in cannabis plants. Yet, quality research is available in regard to terpene-specific benefits, although not all research is available in living models as of yet. B-Caryophyllene, limonene, pinene, linalool, bisabolol, humulene, terpineol, and nerolidol are among those studied for apoptosis effects. As well, limonene, pinene, linalool, eucalyptol, terpineol, and camphene are associated with reduced tumor growth. 

 

Flavonoids account for nearly 10 percent of compounds known in cannabis and may represent up to 2.5 percent of cannabis’ leaf and flower dry weight. They are the largest class of polyphenols. Kaempferol, apigenin, cannflavin B, silymarin, and luteolin are among those researched for tumor-reduction abilities. Kaempferol is also associated with reduced metastasis. Orientin, vitexin, and isovitexin have been studied to induce apoptosis. 

 

Free one on one support

 

If you want to reach out to us to discuss anything cannabinoid therapy related one on one – we are here for you! From quality product selection in your area to dosing guidance along the way, our care team is available. ​​You can call our free hotline at 719-347-5400, email info@realmofcaring.org, or schedule an appointment. 

 

Additional Resources to Support Cancer Prevention

 

American Institute for Cancer Prevention 

 

This year for American Heart Month, the Division for Heart Disease and Stroke Prevention (DHDSP) is encouraging all individuals, but women especially, to focus on their cardiovascular health and to speak up to protect their hearts. Women in the United States are experiencing heart-related illnesses and death at avoidable, yet unacceptable rates due to delayed recognition, diagnosis, and treatment for cardiac events. Heart disease remains the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. 

 

Heart disease and heart attacks may be prevented through healthy lifestyle choices that normalize your blood pressure, cholesterol, and blood sugar levels. These lifestyle choices include healthy food and beverages, maintaining a healthy weight, getting regular physical activity, and abstaining from cigarette smoke. 

 

Cannabidiol (CBD) has been explored for its many therapeutic health benefits, with heart health being one of the areas of research. Specifically, it is being studied for the ways it may help reduce symptoms or prevent heart disease. 

 

CBD is one of two major cannabinoids of the cannabis sativa plant that interacts with our body’s endocannabinoid system (ECS). The ECS is considered the largest neurotransmitter system in the body impacting many functions to include appetite, memory, mood, sleep, and the cardiovascular system. 

 

The ECS and Cardiovascular Function

 

Two key endocannabinoids identified in our ECS are Anandamide (AEA) and 2-arachidonoylglycerol (2-AG). Their role has been associated with mediating low blood pressure as well as normalizing levels of high blood pressure. In recent years we have seen through research that cannabinoids have profound blood pressure-lowering effects on hypertensive animal models but do not have that effect in non-diseased animal models. This leads to the hypothesis that cannabinoids may be used to target hypertension.

 

In certain inflammatory conditions, it has been demonstrated that endocannabinoids are released in large amounts by white blood cells and platelets. They subsequently exert their actions on the heart and vascular cells, which leads to vasodilation, blood pressure lowering, and slowing the heart rate.

 

The role of the ECS has also been studied in metabolic syndrome, a complex and serious health condition that puts individuals at a higher risk of heart disease, diabetes, and stroke. Insulin resistance is believed to play a pivotal role in the pathogenesis of metabolic syndrome. For insulin resistance in the setting of increased caloric intake, insulin amounts increase as the muscle is unable to effectively absorb excess glucose, leading to further insulin production. The excess glucose is converted to extra fat in the liver, increasing free fatty acid levels that cause extra fat deposition on the muscles and organs, ultimately leading to a cycle of abnormally increased insulin in the blood, abnormal inflammation, and increased excess fat. All of these obesity associations can increase cardiovascular disease events. The ECS regulates appetite and food intake through activation of the cannabinoid 1 receptors (CB1). Studies have shown that introducing CB1 antagonists in overweight or obese individuals may induce significant weight loss and improvement of metabolic alterations. 

 

CBD for Cardiovascular Improvements

 

Currently, there are very few natural pharmaceutical solutions available for the treatment of metabolic syndrome. In 2023 researchers published findings analyzing a full-spectrum cannabis oil (CBD:THC, 2:1) to understand the usefulness of cannabis in metabolic syndrome, notably for blood pressure, serum metabolic parameters, and liver damage. Their study showed data that resulted in significant improvements across several metabolic syndrome parameters in animal models fed a sucrose-rich diet. They observed lower systolic and diastolic blood pressure, decreased serum levels, improved liver abnormalities, and pain relief. 

 

Researchers in 2017 reported CBD’s impact on blood pressure in healthy humans following an oral dose of 600mg showing that increased blood pressure levels as a result of stressful situations were weakened. Over time we have seen repeated actions of acute or chronic CBD treatment in reducing the cardiovascular response to models of stress, making it known to be an anxiolytic. 

 

Regarding heart failure, experimental and clinical evidence shows that inflammation is a critical factor in the development and progression of heart failure. CBD has shown a substantial protective effect from fibrosis and inflammation. In models of oxygen deprivation, CBD has been shown to reduce infarct size and increase blood flow in animal models of stroke. 

 

Just as observed with endocannabinoids, CBD also influences the survival and death of white blood cells, white blood cell migration, and platelet aggregation, which offers explanation as to how CBD may have the ability to delay or prevent the development of cardiovascular disorders. 

 

Summary and Next Steps

 

Cannabinoids are being widely recognized across a wide range of therapeutic effects, to include the cardiovascular system. However promising, we still have a lot to understand as far as cannabinoid dosing and interactions with alternative cardiovascular treatments. If you are in need of resources while considering cannabinoid therapy for you or a loved one, Realm of Caring Care Specialists are here to help with free one on one support. Send us an email to info@realmofcaring.org, call us at 719-347-5400, or schedule an appointment online!

 

Additional Heart Healthy Resources

 

• Know Your Risk for Heart Disease
• Heart Healthy Patient Toolkit
• Healthy Eating
• Heart Attack, Stroke, and Cardiac Arrest Symptoms

At Realm of Caring, we believe in the holistic benefits of cannabis and its ability to deepen connections, foster intimacy, and promote wellness. In this guide, we explore how partaking in cannabis together can be quality time, how providing cannabis for your loved one can be an act of service, how cannabis enhances intimacy, and how it facilitates vulnerability and words of affirmation, and provide a list of some of our favorite cannabis brands to give as gifts. So let’s dive in and discover the wonderful world where cannabis meets the love languages! 

 

Quality Time: Partaking in Cannabis Together

 

One of the most beautiful ways to connect with your partner or loved one is by sharing moments of quality time. For many, cannabis serves as a catalyst for meaningful experiences and deep conversations. Whether it’s sharing a joint under the stars, enjoying a cannabis-infused meal together, or simply cuddling on the couch with a CBD-infused beverage, the act of partaking in cannabis can create a sense of closeness and connection that transcends words.

 

Acts of Service: Providing Cannabis for Healing and Wellness

 

In the realm of love languages, acts of service are gestures that demonstrate care, support, and thoughtfulness. For individuals using cannabis for healing or wellness purposes, providing or prepping cannabis-infused products for your partner can be a powerful act of service. From rolling a joint with precision and care to giving a soothing massage with CBD oil, each gesture communicates love, empathy, and a desire for your loved one’s well-being. Brands like Eossi Beauty and Tonico Small Batch CBD offer a range of high-quality products ideal for pampering your partner and supporting their healing journey.

 

Physical Touch: Enhancing Intimacy with Cannabis

 

Cannabis has long been revered for its ability to heighten sensory experiences and deepen physical intimacy. Whether it’s the gentle caress of a partner’s hand, the warmth of a shared embrace, or the heightened sensations during intimate moments, cannabis has the power to amplify connection and pleasure. Incorporating cannabis-infused massage oils, bath bombs, or sensual lubricants can enhance intimacy, promote relaxation, and ignite passion in your relationship.

 

Words of Affirmation: Opening Up with Cannabis

 

In matters of the heart, vulnerability and communication are key. Cannabis has a unique ability to lower inhibitions, quiet the mind, and facilitate open-hearted conversations. For individuals who struggle to express their feelings or fears, cannabis can provide a safe space to share words of affirmation, express gratitude, and deepen emotional bonds. Whether it’s whispering sweet nothings under the influence of a relaxing indica strain or expressing profound truths during a heart-to-heart conversation, cannabis can help cultivate a sense of trust, understanding, and love.

 

Gifts for the Cannabis Enthusiast

 

For those who appreciate the gesture of receiving gifts, cannabis products offer a thoughtful and meaningful way to express love and appreciation. Consider shopping through one of the brands listed below to support Realm of Caring. Browse through some of these offers and maybe you’ll find the perfect gift for the cannabis enthusiast in your life!

 

• Eossi Beauty: use code CARING for 30% off your purchase
• Element Apothec: use code ROCSAVE for 15% off your purchase
• The Functional Chocolate Company: use code REALM of 20% off your purchase
• Woven Earth: use code ROC20 for 20% off your purchase (of $88 or more)
• Extract Consultants: use code ROC10 for 10% off your purchase
• Tonico: use code CARING for 15% off your purchase
• Bloom: use code GREENNURSE for 10% off + free shipping
• Made by Mary: use code REALMOFCARING for 20% off

 

At Realm of Caring, we believe that love knows no bounds, and neither does the healing power of cannabis. By embracing the love languages of quality time, acts of service, physical touch, words of affirmation, and gift giving, you can deepen your connections, nurture your relationships, and cultivate a sense of love and well-being that transcends boundaries. 

 

The Endocannabinoid System (ECS) has been found to be present in vertebrates (mammals, birds, reptiles, and fish) and invertebrates (sea urchins, leeches, mussels, nematodes, and others). It regulates sleep, appetite, behavior, and multiple metabolic processes. The ECS also plays an important role in pathologies that affect other organs and systems, working to restore homeostasis. Scientific evidence of the ability of phytocannabinoids to assist the ECS in regulation is growing, even in the realm of veterinary medicine to understand the potential benefits in alleviating symptoms associated with different animal disorders. 

 

Despite legal restraints from country to country, use of cannabinoids in dogs, cats, and horses have been reported to include:

 

• Reduction in anxiety
• Reduction in pain
• Improvement in mobility issues associated with osteoarthritis
• Regulation of appetite
• Control of type 2 diabetes
• Control of inflammatory conditions
• Lessened epileptic episodes

 

Published results from a United States survey reported that nearly 60% of pet owners give or were giving cannabidiol (CBD) to their dogs and 12% reported the same for their cats. From these, 64% found it helped with pain reduction, 50% found it helped with sleep, 49% found it reduced anxiety, and 30% found it reduced convulsions. 

 

Argentinian Study Shows Promise

 

Between May and November 2021, Argentinian Cannabis Veterinarians conducted the first national survey to assess and evaluate cannabinoid therapy treatments provided by veterinarians to dogs and cats. Results were published in 2023. The survey evaluated the following comprehensive list:

 

• Location of the practitioner
• Species treated
• Breed
• Age
• Weight
• Pathology
• Type of feeding
• Treatments implemented
• Type and concentration of cannabis (full spectrum THC dominant, full spectrum CBD dominant, or a full spectrum 1:1 ratio)
• Route
• Dose

 

Of the treated species, 77% were dogs and 21% were cats. 

 

Dogs

The dog ages ranged between 0.4 and 19 years old. Pain was the most prevalent condition followed by behavioral and seizures. Remaining disorders included distemper, cancer, senile cognitive dysfunction, and dermatopathies. Veterinarians determined the cannabis oil type based on the condition. For example, 97% of dog patients with pain were treated with either a THC dominant or 1:1 ratio formulation, whereas 58% of dog patients with behavioral disorders and 54% of dog patients with seizures received the CBD dominant formula. 

 

Among the dogs treated for pain, 37% showed significant improvement after 15 days of treatment and 80% showed significant improvement after 60 days of treatment using the THC dominant formula. Those treated with the 1:1 ratio formula saw a significant improvement of 75% after 15 days. Dogs with seizures and behavioral disorders using CBD dominant formulas witnessed reduced seizure frequency, duration, and intensity in epileptic conditions. They also had minimized behavioral disorders such as anxiety, restlessness and compulsive behaviors. 

 

Of the 89 dogs who received cannabis oil, 28 were using it as a standalone therapy without any other medication.

 

Reported adverse effects for the dog patient group  included lethargy and one case of a paranoid state with a patient taking other medication and with a pre-existing behavioral disorder. 

 

Cats

 

The age range of cat patients was similar to dogs at 2 years to 18 years old, although a smaller group was observed. The main diseases and conditions observed included behavioral disorders, pain, gingivostomatitis, dermatopathies, autoimmune diseases, and combinations of two or more conditions. 

 

THC dominant, 1:1 ratio, and CBD dominant formulas were used for cats with pathologies such as behavioral disorders, pain, and cancer. Dermic pathologies were mostly treated with just the CBD dominant formula. The THC dominant formula showed a 66% improvement at 15 days while the CBD dominant formula showed a significant improvement of 43% at 15 days and 75% at 30 days. 

 

For cats, the use of the cannabinoid products alone or combined with other medications improved clinical parameters. Ten cats received cannabis as their single therapy. Just as with the dog group, veterinarians and caregivers saw a reduction of clinical signs and symptoms at 15, 30, and 60 days. 

 

Study Takeaways

 

This exploratory study presented the opportunity to determine the status of cannabinoid therapy in veterinary medicine. In all cases, veterinarians and caregivers both reported a positive perception of treatments, indicating moderate to significant improvements in the quality of life at 15, 30, and 60 days. The promising results support the case to develop a plan that builds solid scientific evidence. Researchers also advocate for the education of the ECS for veterinarians, understanding the quality and safety of products before recommending to animal patients, initiating treatments at the lowest possible dose, and closely documenting health outcomes. 

 

Finding Support

 

Looking for guidance on locating quality products and dosing? The care team at Realm of Caring is here to assist by offering up-to-date research resources and one-on-one support. Call 719-347-5400, email info@realmofcaring.org, or schedule an appointment to get in touch. 

Among the most common injuries to the musculoskeletal system are bone fractures. They most often happen when more force is applied to the bone than the bone can take. This can happen as a result of falling, trauma, or a direct blow to the body. Overuse or repetitive motions may also lead to a stress fracture by tiring muscles, which then put more pressure on the bone, an occurrence more commonly found in athletes. Diseases that weaken the bone may also lead to a fracture, such as osteoporosis or a cancer-induced bone disease. Symptoms of a fractured bone may include:

 

• Sudden pain
• Trouble using or moving the injured area or nearby joints
• Swelling
• Obvious deformity
• Warmth, bruising, or redness

 

Fracture healing takes time as new bone is formed between the broken parts. The process of healing starts immediately after injury, at a cellular level, and continues thereafter. Components in the healing process are broken up into three main phases: inflammation, repair, and remodeling. 

 

Current pain management used for bone fractures are nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids. However research indicates that NSAIDs may inhibit bone repair by preventing the critical inflammatory phase. Opioids have not proved to offer a better alternative as they may interfere with the functional status of patients, where effective healing of a load-bearing bone requires proper micro-movement and weight-baring. Therefore, delaying movement may delay healing and/or lead to further bone loss and additional broken bones. There is a clinical need to address pain management while not negatively impacting the healing process. 

 

It has been previously researched the potential role cannabinoids may have in aiding bone health. This is due to the endocannabinoid system (ECS) being connected to the regulation of bone cell activity and bone remodeling. Studies have shown that endogenous cannabinoid ligands, cannabinoid receptors, and enzymes all play key roles in bone mass and in the regulation of bone disease. The main endocannabinoids, anandamide and 2-arachidonoyl glycerol (2-AG), are present in bone tissue at levels similar to those found in the brain. CB2 receptors are expressed in bone cells and have been discovered to have a bone anabolic action. Considering the involvement of the ECS in bone remodeling, modulation of the ECS could offer a possible treatment where bone loss is observed. 

 

A limited number of studies have looked to cannabidiol (CBD) for its impact on fracture healing and bone homeostasis. In 2015, Kogan et al. suggested that CBD-induced stimulation of fracture healing takes place in the later phases of healing, increasing the toughness of the bone 8 weeks after fracture. Researchers concluded that “CBD alone is sufficiently effective in enhancing fracture healing”. In 2017, Li et al. used rodent models to investigate the therapeutic effect of CBD on severe bone loss due to spinal cord injury. Treatment with CBD provided the first direct indication of evidence that CBD prevents sublesional bone loss and deterioration of trabecular bone subsequent to spinal cord injury. 

 

Recognizing that the investigation of cannabinoids for their therapeutic potential in managing fracture pain is in its infancy,  Kumar Khajuria et al. used a mouse model of endochondral fracture healing to assess the impact of CBD and cannabigerol (CBG) on the different phases on healing and pain managing effects. CBG is far less studied, however derivatives have shown to modulate inflammation and immune response, much like that of CBD. Using the mouse model, they assessed the efficacy of CBD and CBG in post-fracture pain and their influence on the structure and quality of the newly formed bone. Results were published in 2023.

 

In the set of pain behavior tests, both CBD and CBG ameliorated post-fracture pain as effectively as NSAIDs, proposing their use as efficacious alternatives in managing pain in fracture patients. Additional results after day 14 post-fracture, indicated that consistent treatment with CBD and CBG promoted bone formation. Specifically, CBD and CBG increased the number of osteoblasts (cells that form bone tissue) per bone surface area and induced the proliferation of bone lining cells. Later in the healing stage, at day 28 post-fracture, no significant difference in the stiffness was observed however CBD and CBG substantially increased the biomechanical strength of the healed bone. This collective data indicates striking similarities that both CBD and CBG promote bone formation and fracture repair throughout the healing process. 

 

Bone fractures are considered a global public health issue. Osteoporosis alone causes more than 8.9 million fractures annually. Alternative therapies and preventative measures are needed, especially those that may ameliorate pain while improving the healing process. While research for cannabinoid use in this matter is limited to date, results thus far are promising and pave the way for more research to take place. 

 

Finding Support

 

There is a lot to consider when starting cannabinoid therapy but, as always, a Realm of Caring care specialist is here to help with free one-on-one support to answer your questions. Contact us today by calling (719) 347-5400 or by emailing info@realmofcaring.org.

In recent years, the cannabis plant has emerged as a surprising ally in the battle against weight gain, with certain strains showing promise for weight management. Among these, Tetrahydrocannabivarin (THCV) has been gaining attention as “nature’s ozempic,” due to its potential in aiding weight loss and managing appetite.

 

THCV: Nature’s Answer to Weight Loss?

 

THCV, a compound found in cannabis, differs from THC in its effects on appetite and metabolism. Unlike THC, which is known to stimulate appetite, THCV has been observed to decrease appetite and increase energy metabolism in rodent models. This unique property of THCV makes it an intriguing option for weight management and the treatment of obesity and diabetes​​.

 

The Endocannabinoid System (ECS) is a complex network of receptors found throughout the body, including the brain, organs, connective tissues, glands, and immune cells. The primary function of the ECS is to maintain bodily homeostasis—biological harmony in response to environmental changes. The ECS comprises mainly two types of receptors: CB1 and CB2.

 

THCV is known to act as a CB1 antagonist and a CB2 partial agonist. As an antagonist, THCV blocks the action of cannabinoids at the CB1 receptor, especially in the central nervous system. This action is crucial because CB1 receptors are widely implicated in appetite regulation and feeding behavior. By blocking CB1 receptors, THCV can potentially reduce hunger and prevent overeating.

 

Moreover, in lower doses, THCV appears to act as a CB1 antagonist, but in higher doses, it may start to activate CB1 receptors, albeit less intensely than THC. This dual action makes THCV an interesting subject for research in appetite control and weight management.

 

Research suggests that THCV may also influence metabolism. By interacting with the ECS, particularly through the CB2 receptors, THCV might help in regulating blood sugar levels and reducing insulin resistance. This is particularly significant for individuals with obesity or type 2 diabetes, where insulin resistance is a common issue.

 

Four Cannabis Strains for Weight Loss

 

Beyond THCV, several other cannabis strains are notable for their potential in aiding weight loss. Here are four strains that might help:

 

• Remedy: This strain is known for its high CBD content and low THC levels. It’s reported to relieve stress and anxiety without causing the munchies​​.
• ACDC: Another high-CBD, low-THC strain, ACDC is chosen for pain management and relaxation, also avoiding the munchies​​.
• Lifter: With its high CBD percentage and almost no THC, Lifter is a popular choice for daytime use, enhancing mood without intoxicating effects​​.
• Cherry Wine: This strain is appreciated for its relaxation benefits after a long day and its high CBD content, making it unlikely to trigger hunger pangs​​.

 

CBD Oil and Weight Loss: The Science of Fat Browning

 

An intriguing aspect of weight loss research is the role of CBD oil in promoting the browning of fat cells. This process is essential for generating heat by burning calories, aiding in weight loss. CBD, a major cannabinoid found in cannabis, may contribute to the transformation of white fat into brown fat, which is more metabolically active and burns more calories. This transformation is a promising area of research for those looking to manage their weight more effectively​​.

 

The Endocannabinoid System and Appetite

 

The Endocannabinoid System (ECS) in our bodies plays a crucial role in appetite control. It influences everything from appetite suppression to the treatment of conditions that involve reduced appetite and weight loss. CBD, as a cannabinoid receptor antagonist, may help manage obesity, while THC, a receptor agonist, might be a therapy option for conditions like anorexia​​.

 

In conclusion, THCV presents a fascinating aspect of cannabis research, especially in the context of weight management and metabolic health. Its unique interaction with the ECS, particularly its antagonistic action on CB1 receptors and potential metabolic benefits, make it a cannabinoid of interest for further study in the realm of obesity, diabetes, and general wellness.

 

As the understanding of cannabis and its components deepens, it’s clear that certain strains and compounds have significant potential in weight management. With strains like Remedy, ACDC, Lifter, and Cherry Wine offering benefits without the munchies, and CBD oil promoting the browning of fat cells, cannabis is showing itself to be a valuable tool in the journey towards a healthier weight.

A new year allows us the opportunity to reflect on the past year to understand what we want to let go of and what we want to prioritize in the year ahead. One priority that many have at the top of their list is improving individual mental health wellness with natural remedies. To aid in that journey to become the best versions of ourselves, we have gathered up key guidance and resources on how cannabinoids such as cannabidiol (CBD) may benefit us from the inside out. 

 

Being consistent in the short-term for long-term goals

 

Among the questions we receive, one of the more frequently asked is how and when to take CBD products. When it comes to your therapy, consistency is key to successful results. For CBD in particular, this is for a couple of reasons. 

 

First, CBD has a low bioavailability and a short half-life. Consistent dosing 2-3 times daily may allow CBD, among other minor cannabinoids, to remain present in your body to offer the beneficial effects you are looking for. While the amount you take and how often you dose is highly dependent on your specific needs and situation, a Realm of Caring care specialist is here to help with free one-on-one support to help find what is right for you.

 

Secondly, given that CBD has low bioavailability and a fairly short half-life. It may take time for the cannabinoids to fully present themselves and for the benefits to be revealed to the consumer. Therefore it is advised to be patient before increasing the amount you are taking. Increasing too much too soon may lead to undesired effects while taking too little may provide no benefit. The key is to find your individual, therapeutic dose.

 

Implementing self-care rituals 

 

Engaging in a self care routine has been clinically proven to reduce or eliminate anxiety and depression, reduce stress, improve concentration, minimize frustration and anger, increase happiness, and improve energy.

 

There is a continuous need to seek more efficient, safer, and widely available methods to treat medical conditions, skin pathology included. Topical use of cannabis as a form of therapy covers a wide scope of skin disorders due to anti-inflammatory, anti-itching, wound healing, anti-microbial, and anti-proliferative effects. 

 

Elements of the ECS have been discovered in the skin, to include our skin’s immune system. Through interaction of the receptors in our skin layers, cannabinoids have shown through research to alter pain, stimulate wound healing, and alleviate itch. These studies may add a different dimension on how we see the treatment of several skin diseases. 

 

Of the cannabinoids researched to date for skin health, CBD is a widespread ingredient in skin care products formulated as body oils, moisturizers, salves, lotions, and balms. Delta-9-Tetrahydrocannabinol (THC), and potentially cannabinol (CBN), may also be responsible for skin benefits such as reducing cytokine production and oxidative stress. Additionally, cannabigerol (CBG) has powerful anti-inflammatory and antibacterial properties that may add benefit to our skin health. 

 

Keeping your gut in check 

 

Our gut health is a complex ecosystem, composed of over 1,000 microorganisms. These microorganisms have significant roles in our daily energy uptake by breaking down complex carbohydrates into simple sugars. They also impact our immune system and imbalances of the gut may contribute to weight fluctuations, obesity, food sensitivity and more. 

 

In addition, you may be familiar with the brain-gut connection (sometimes referred to as gut-brain), which helps us to understand how functional bowel problems and bowel disorders such as Irritable Bowel Syndrome (IBS) may be responsible for sending signals to the central nervous system that trigger mood changes, leading to anxiety and depression. 

 

The ECS performs protective activities in our gastrointestinal (GI) tract and shows promise as a therapeutic target against bowel disorders such as IBS, Crohn’s disease, irritable bowel disease (IBD), and motility-related conditions. The main role of the ECS in the GI tract is controlling intestinal hyper-contractility, modulating visceral sensations, intestinal inflammation, and brain-gut communication. 

 

A significant population of individuals suffering with IBD use cannabis to relieve symptoms of pain, nausea, and appetite, as well as to improve their overall mood. THC has been shown through anecdotal evidence to improve abdominal spasms, cramps, and visceral pain; whereas CBD may contribute to the relief of intestinal inflammation, modulating cortisol and metabolism, improve the immune response of the gut, and alleviate the anxiety and stress associated with gastrointestinal discomfort. In a 2021 review of 682 studies of cannabinoid use for IBD patients, clinical symptoms (abdominal pain, general well-being, nausea, diarrhea, and poor appetite) were all improved with cannabinoid therapy. 

 

Fostering clarity and focus

 

Proper cognition and energy levels throughout the day can be attributed to healthy sleep. CBD is among those cannabinoids that may help eliminate brain fog during the day, while also improving our sleep quality during the night. 

 

CBD has therapeutic properties that have the potential to mitigate symptoms that interfere with sleep. It also has the potential to improve sleep-wake cycles leading to an increase in the percentage of total quality sleep overtime.

 

Prolonged CBD therapy has shown positive improvements in psychological symptoms and cognition. Currently, using cannabinoids to benefit neurological issues and serve as a neuroprotectant is being studied. The antioxidant properties of cannabinoids, such as CBD, may have the ability to provide neuroprotection. As well, research is showing that elevation of cannabinoid receptor activity could potentially slow down the progression of brain aging and alleviate symptoms associated with neurodegenerative disorders, therefore cannabinoids with the ability to activate receptors may provide these additional benefits. 

 

Additional ingredients in your cannabinoid product may also enhance cognitive function in your day to day. For example, lemon balm is known to improve mood, cognition, and aid as a natural anti-inflammatory, anti-oxidant, and decongestant. Combining CBD and lemon balm may calm the nervous system to ease stress, refocus energy, and relax. The functional mushroom, lion’s mane, is another ingredient known to have a host of benefits for neurodegenerative diseases such as ischemic stroke, Parkinson’s, Alzheimer’s, and depression. It may also promote recovery and enhance nerve regeneration, therefore improving cognitive performance and reducing brain fog. 

 

Finding support

 

When looking to cannabis for medical conditions, we always recommend speaking with a healthcare professional. However, if you are in need of support while on your journey we are here to help. From product selection to dosing guidance to answering questions your family has about your decision to choose cannabis – we are here every step of the way. Send as an email to info@realmofcaring.org, call us at 719-347-5400 or chat with us at realmcaring.org.